IDEAYA Biosciences, Inc. (IDYA)
36.11
+0.05
(+0.14%)
USD |
NASDAQ |
Oct 09, 16:00
35.60
-0.51
(-1.41%)
After-Hours: 20:00
IDEAYA Biosciences EPS Diluted (Quarterly) : -1.222 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.222 |
| March 31, 2026 | -1.111 |
| December 31, 2025 | -0.9401 |
| September 30, 2025 | 1.330 |
| June 30, 2025 | -0.8759 |
| March 31, 2025 | -0.8169 |
| December 31, 2024 | -1.492 |
| September 30, 2024 | -0.6012 |
| June 30, 2024 | -0.6769 |
| March 31, 2024 | -0.5269 |
| December 31, 2023 | -0.5204 |
| September 30, 2023 | -0.4573 |
| June 30, 2023 | -0.4964 |
| March 31, 2023 | -0.4887 |
| December 31, 2022 | -0.5028 |
| September 30, 2022 | 0.0393 |
| June 30, 2022 | -0.5705 |
| Date | Value |
|---|---|
| March 31, 2022 | -0.3631 |
| December 31, 2021 | -0.473 |
| September 30, 2021 | -0.3066 |
| June 30, 2021 | -0.3332 |
| March 31, 2021 | -0.284 |
| December 31, 2020 | -0.1762 |
| September 30, 2020 | -0.1735 |
| June 30, 2020 | -0.59 |
| March 31, 2020 | -0.5947 |
| December 31, 2019 | -0.5333 |
| September 30, 2019 | -0.5442 |
| June 30, 2019 | -1.297 |
| March 31, 2019 | -0.473 |
| December 31, 2018 | -0.4216 |
| September 30, 2018 | -0.6452 |
| June 30, 2018 | -0.3458 |
| March 31, 2018 | -0.2836 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 0.3068 |
| Xencor, Inc. | -0.2864 |
| BioMarin Pharmaceutical, Inc. | 0.2302 |
| MediciNova, Inc. | -0.047 |
| Viking Therapeutics, Inc. | -1.101 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -112.45M |
| Revenue (Quarterly) | 8.857M |
| Total Expenses (Quarterly) | 121.31M |
| Enterprise Value | 2.680B |
| Gross Profit Margin (Quarterly) | 87.21% |
| Profit Margin (Quarterly) | -1.27K% |
| Earnings Yield | -5.38% |
| Normalized Earnings Yield | -5.381 |